MLTX · MoonLake Immunotherapeutics
Market Cap
$1.32B
Shares
85.11M
MoonLake Immunotherapeutics Earnings Call Transcripts
Quarterly earnings calls for MoonLake Immunotherapeutics (MLTX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Conference
Investor event
2026-11-11
MoonLake Immunotherapeutics (MLTX) November 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-10
MoonLake Immunotherapeutics (MLTX) November 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-16
MoonLake Immunotherapeutics (MLTX) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-16
MoonLake Immunotherapeutics (MLTX) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-11
MoonLake Immunotherapeutics (MLTX) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-10
MoonLake Immunotherapeutics (MLTX) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-10
MoonLake Immunotherapeutics (MLTX) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-23
MoonLake Immunotherapeutics (MLTX) Q4 2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2024-08-07
MoonLake Immunotherapeutics (MLTX) Q2 2024 Earnings Call
Diluted EPS
$-0.39
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
MoonLake Immunotherapeutics (MLTX) Q4 2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q2
2023-08-10
MoonLake Immunotherapeutics (MLTX) Q2 2023 Earnings Call
Diluted EPS
$-0.23
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-20
MoonLake Immunotherapeutics (MLTX) Q4 2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–12 of 12 earnings calls
Key facts
CIK
1821586
CUSIP
61559X104
13F (30d)
168 filings
161 filers
Visit website
Investor relations